{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:37:04Z","timestamp":1792690624823,"version":"4.5.0"},"reference-count":135,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T00:00:00Z","timestamp":1252454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0006963","type":"journal-article","created":{"date-parts":[[2009,9,8]],"date-time":"2009-09-08T22:21:02Z","timestamp":1252448462000},"page":"e6963","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["Islet Endothelial Activation and Oxidative Stress Gene Expression Is Reduced by IL-1Ra Treatment in the Type 2 Diabetic GK Rat"],"prefix":"10.1371","volume":"4","author":[{"given":"Gr\u00e9gory","family":"Lacraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Giroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Kassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Coulaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Galinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Cornut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Schmidlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Janel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Irminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheline","family":"Kergoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Portha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Y.","family":"Donath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Ehses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Homo-Delarche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.","volume":"108","author":"MA Creager","year":"2003","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications.","volume":"414","author":"M Brownlee","year":"2001","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/ars.2007.1610","article-title":"Isletopathy in Type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress.","volume":"9","author":"MR Hayden","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.2741\/3133","article-title":"Loss of beta-cells with fibrotic islet destruction in type 2 diabetes mellitus.","volume":"13","author":"JW Kim","year":"2008","journal-title":"Front Biosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00125-003-1304-4","article-title":"Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?","volume":"47","author":"A Clark","year":"2004","journal-title":"Diabetologia"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2337\/db05-1526","article-title":"Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat.","volume":"55","author":"F Homo-Delarche","year":"2006","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/157339507781483478","article-title":"Islet inflammation in type 2 diabetes (T2D): from endothelial to beta-cell dysfunction.","volume":"3","author":"JA Ehses","year":"2007","journal-title":"Cur Immunol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2337\/db06-1650","article-title":"Increased number of islet-associated macrophages in type 2 diabetes.","volume":"56","author":"JA Ehses","year":"2007","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.2337\/dc08-s243","article-title":"Islet inflammation in type 2 diabetes: from metabolic stress to therapy.","volume":"31","author":"MY Donath","year":"2008","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0168-8227(95)01155-2","article-title":"The endocrine pancreas of spontaneously diabetic db\/db mice: microangiopathy as revealed by transmission electron microscopy.","volume":"30","author":"M Nakamura","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2337\/db06-0733","article-title":"Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes.","volume":"55","author":"X Li","year":"2006","journal-title":"Diabetes"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/edrv.22.1.0417","article-title":"Diabetes and endothelial dysfunction: a clinical perspective.","volume":"22","author":"J Calles-Escandon","year":"2001","journal-title":"Endocr Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.","volume":"112","author":"X Du","year":"2003","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.arcmed.2005.11.012","article-title":"Oxidative stress at the vascular wall. Mechanistic and pharmacological aspects.","volume":"37","author":"A Rojas","year":"2006","journal-title":"Arch Med Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1185\/030079905X36440","article-title":"PPARgamma and atherosclerosis.","volume":"21","author":"B Staels","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","article-title":"Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.","volume":"24","author":"A Ceriello","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism.","volume":"54","author":"M Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20050025","article-title":"Vascular complications in diabetes mellitus: the role of endothelial dysfunction.","volume":"109","author":"CG Schalkwijk","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.","volume":"404","author":"T Nishikawa","year":"2000","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1196\/annals.1372.022","article-title":"Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus.","volume":"1084","author":"FN Ahmed","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc06-2484","article-title":"Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.","volume":"30","author":"JB Meigs","year":"2007","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"30369","DOI":"10.1074\/jbc.M400549200","article-title":"Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.","volume":"279","author":"PC Schulze","year":"2004","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1096\/fasebj.6.8.1592209","article-title":"Cytokine regulation of endothelial cell function.","volume":"6","author":"A Mantovani","year":"1992","journal-title":"Faseb J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"53988","DOI":"10.1074\/jbc.M404809200","article-title":"Adenoviral overexpression of the glutamylcysteine ligase catalytic subunit protects pancreatic islets against oxidative stress.","volume":"279","author":"PO Tran","year":"2004","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis.","volume":"84","author":"R Stocker","year":"2004","journal-title":"Physiol Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.abb.2003.12.008","article-title":"Redox events in interleukin-1 signaling.","volume":"423","author":"R Brigelius-Flohe","year":"2004","journal-title":"Arch Biochem Biophys"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","article-title":"NF-kappaB activation by reactive oxygen species: fifteen years later.","volume":"72","author":"G Gloire","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways.","volume":"86","author":"A Tedgui","year":"2006","journal-title":"Physiol Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus.","volume":"356","author":"CM Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2007-1059","article-title":"The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia.","volume":"149","author":"NS Sauter","year":"2008","journal-title":"Endocrinology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/187152508783955006","article-title":"IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications.","volume":"6","author":"S Apostolakis","year":"2008","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2008.06.013","article-title":"The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?","volume":"297","author":"B Portha","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1161\/atvb.21.9.1385","article-title":"Does homocysteine promote atherosclerosis?","volume":"21","author":"SR Lentz","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2007.07.022","article-title":"Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats.","volume":"574","author":"M Sharma","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2362.2007.01879.x","article-title":"Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice.","volume":"37","author":"J Hamelet","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.","volume":"101","author":"KS Michelsen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00041433-200410000-00004","article-title":"Functional role for toll-like receptors in atherosclerosis and arterial remodeling.","volume":"15","author":"A Vink","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1189\/jlb.1206761","article-title":"Chemokine regulation of atherosclerosis.","volume":"82","author":"J Barlic","year":"2007","journal-title":"J Leukoc Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood.V69.2.695.695","article-title":"Modulation of endothelial cell functions by different molecular species of interleukin 1.","volume":"69","author":"E Dejana","year":"1987","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0167-5699(97)81662-3","article-title":"Cytokine regulation of endothelial cell function: from molecular level to the bedside.","volume":"18","author":"A Mantovani","year":"1997","journal-title":"Immunol Today"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/bj1990393","article-title":"CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse.","volume":"199","author":"K Grankvist","year":"1981","journal-title":"Biochem J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0891-5849(96)02051-5","article-title":"Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues.","volume":"20","author":"S Lenzen","year":"1996","journal-title":"Free Radic Biol Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2337\/diabetes.51.2.413","article-title":"Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia.","volume":"51","author":"DR Laybutt","year":"2002","journal-title":"Diabetes"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e6500","DOI":"10.1371\/journal.pone.0006500","article-title":"Diabetic beta-cells can achieve self-protection against oxidative stress through an adaptative up-regulation of their antioxidant defenses.","volume":"(8)","author":"G Lacraz","year":"2009","journal-title":"PLoS ONE 4"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.molimm.2004.09.029","article-title":"L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?","volume":"42","author":"JJ Haddad","year":"2005","journal-title":"Mol Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s00125-003-1174-9","article-title":"Haeme-oxygenase 1 expression in rat pancreatic beta cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP.","volume":"46","author":"JC Jonas","year":"2003","journal-title":"Diabetologia"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm0196-87","article-title":"Heme oxygenase: a novel target for the modulation of the inflammatory response.","volume":"2","author":"D Willis","year":"1996","journal-title":"Nat Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1172\/JCI115666","article-title":"Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.","volume":"89","author":"JB Hibbs Jr","year":"1992","journal-title":"J Clin Invest"},{"key":"ref49","first-page":"H883","article-title":"Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells.","volume":"274","author":"CM Terry","year":"1998","journal-title":"Am J Physiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1172\/JCI119634","article-title":"Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.","volume":"100","author":"K Ishikawa","year":"1997","journal-title":"J Clin Invest"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1074\/jbc.M211898200","article-title":"Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.","volume":"278","author":"MK Kwak","year":"2003","journal-title":"J Biol Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"13998","DOI":"10.1073\/pnas.0810087106","article-title":"IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat.","volume":"106","author":"JA Ehses","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbrc.2003.12.180","article-title":"Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats.","volume":"314","author":"T Masuyama","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbrc.2004.02.023","article-title":"Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats.","volume":"316","author":"SH Ko","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.HYP.37.2.433","article-title":"Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.","volume":"37","author":"ZJ Cheng","year":"2001","journal-title":"Hypertension"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2005.01.014","article-title":"Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.","volume":"511","author":"MS Bitar","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.2337\/diabetes.54.9.2638","article-title":"Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1.","volume":"54","author":"AK Harris","year":"2005","journal-title":"Diabetes"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/db07-0426","article-title":"Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes.","volume":"56","author":"K Sachidanandam","year":"2007","journal-title":"Diabetes"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nutres.2007.12.005","article-title":"Supplementation of Coenzyme Q<sub>10<\/sub> and alpha-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats.","volume":"28","author":"C Sena","year":"2008","journal-title":"Nutrition Research"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0162-3109(98)00024-1","article-title":"Glycated serum stimulation of macrophages in GK- and streptozotocin-rats for the proliferation of primary cultured smooth muscle cells of the aorta.","volume":"40","author":"I Kimura","year":"1998","journal-title":"Immunopharmacology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00125-004-1416-5","article-title":"Enhanced insulin secretion and cholesterol metabolism in congenic strains of the spontaneously diabetic (Type 2) Goto Kakizaki rat are controlled by independent genetic loci in rat chromosome 8.","volume":"47","author":"RH Wallis","year":"2004","journal-title":"Diabetologia"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s00125-006-0396-z","article-title":"Genetic control of plasma lipid levels in a cross derived from normoglycaemic Brown Norway and spontaneously diabetic Goto-Kakizaki rats.","volume":"49","author":"K Argoud","year":"2006","journal-title":"Diabetologia"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","article-title":"Leptin and atherosclerosis.","volume":"189","author":"J Beltowski","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.3945\/jn.108.090704","article-title":"The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects.","volume":"138","author":"KB Holven","year":"2008","journal-title":"J Nutr"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0021-9150(93)90183-U","article-title":"Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.","volume":"104","author":"MI Mackness","year":"1993","journal-title":"Atherosclerosis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.","volume":"101","author":"M Aviram","year":"1998","journal-title":"J Clin Invest"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.freeradbiomed.2008.02.012","article-title":"Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties.","volume":"44","author":"O Rozenberg","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0021-9150(03)00236-3","article-title":"Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.","volume":"170","author":"J Beltowski","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.52.5.1256","article-title":"High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells.","volume":"52","author":"N Shanmugam","year":"2003","journal-title":"Diabetes"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2337\/db07-1520","article-title":"Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators.","volume":"57","author":"JV Busik","year":"2008","journal-title":"Diabetes"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/CIRCRESAHA.106.142851","article-title":"Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity.","volume":"100","author":"F Kim","year":"2007","journal-title":"Circ Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20060342","article-title":"Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.","volume":"112","author":"S Higuchi","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.abb.2003.12.017","article-title":"Reactive nitrogen species in the chemical biology of inflammation.","volume":"423","author":"PC Dedon","year":"2004","journal-title":"Arch Biochem Biophys"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/er.2007-0033","article-title":"Cytokines and beta-cell biology: from concept to clinical translation.","volume":"29","author":"MY Donath","year":"2008","journal-title":"Endocr Rev"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/15438600490898609","article-title":"Glucose intolerance and hyperlipidemia prior to diabetes onset in female Spontaneously Diabetic Torii (SDT) rats.","volume":"5","author":"M Shinohara","year":"2004","journal-title":"Exp Diabesity Res"},{"key":"ref76","first-page":"S308, Abstract 771","article-title":"The prediabetic period is characterized by islet microangiopathy in the Goto-Kakizaki rat, a spontaneous model of type 2 diabetes.","volume":"51","author":"F Homo-Delarche","year":"2008","journal-title":"Diabetologia"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00125-007-0676-2","article-title":"Defective IGF2 and IGF1R protein production in embryonic pancreas precedes beta cell mass anomaly in the Goto-Kakizaki rat model of type 2 diabetes.","volume":"50","author":"S Calderari","year":"2007","journal-title":"Diabetologia"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"456S","DOI":"10.1093\/ajcn\/83.2.456S","article-title":"Inflammation and cardiovascular disease mechanisms.","volume":"83","author":"P Libby","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1189\/jlb.1206756","article-title":"Caspase-1 inflammasomes in infection and inflammation.","volume":"82","author":"M Lamkanfi","year":"2007","journal-title":"J Leukoc Biol"},{"key":"ref80","first-page":"S177, Abstract 414","article-title":"Beta cells of the diabetic Goto-kakizaki rat exhibit an unexpected in vitro adaptation to oxidative stress-induced apoptosis.","volume":"50","author":"G Lacraz","year":"2007","journal-title":"Diabetologia"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00125-007-0734-9","article-title":"Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.","volume":"50","author":"L Zheng","year":"2007","journal-title":"Diabetologia"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1073\/pnas.95.8.4556","article-title":"Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury.","volume":"95","author":"P Wang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.","volume":"87","author":"K Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2006.12.034","article-title":"Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.","volume":"561","author":"H Ding","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"e2165","DOI":"10.1371\/journal.pone.0002165","article-title":"Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.","volume":"3","author":"A Salehi","year":"2008","journal-title":"PLoS One"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00125-006-0462-6","article-title":"Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line.","volume":"50","author":"D Morgan","year":"2007","journal-title":"Diabetologia"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbadis.2006.11.011","article-title":"High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: implications for atherosclerosis.","volume":"1772","author":"T Hayashi","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coph.2003.12.003","article-title":"Cyclooxygenase-2 and inflammation in atherosclerosis.","volume":"4","author":"MF Linton","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbrc.2007.08.090","article-title":"Effect of selective cyclooxygenase-2 (COX-2) inhibitor treatment on glucose-stimulated insulin secretion in C57BL\/6 mice.","volume":"363","author":"H Fujita","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/FJC.0b013e31813c6cc3","article-title":"Mechanisms of ET-1-induced endothelial dysfunction.","volume":"50","author":"M Iglarz","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1440-1681.2007.04830.x","article-title":"Endothelins and NADPH oxidases in the cardiovascular system.","volume":"35","author":"KJ Dammanahalli","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1155\/S0962935193000596","article-title":"Endothelin-1 stimulates human monocytes in vitro to release TNF-alpha, IL-1beta and IL-6.","volume":"2","author":"E Helset","year":"1993","journal-title":"Mediators Inflamm"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"E1616","DOI":"10.1152\/ajpendo.00640.2006","article-title":"Endothelin-1 and pancreatic islet vasculature: studies in vivo and on isolated, vascularly perfused pancreatic islets.","volume":"292","author":"EY Lai","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1113\/jphysiol.2006.126193","article-title":"The physiology of a local renin-angiotensin system in the pancreas.","volume":"580","author":"PS Leung","year":"2007","journal-title":"J Physiol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"R1619","DOI":"10.1152\/ajpregu.00290.2007","article-title":"Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis.","volume":"293","author":"P Chen","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.ATV.0000254814.63768.3b","article-title":"Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma.","volume":"27","author":"W Hodroj","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1161\/01.CIR.0000150540.54220.C4","article-title":"Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.","volume":"110","author":"A Daugherty","year":"2004","journal-title":"Circulation"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/db06-0288","article-title":"Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.","volume":"56","author":"JH Oak","year":"2007","journal-title":"Diabetes"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.bbrc.2006.04.011","article-title":"Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db\/db mice.","volume":"344","author":"J Shao","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00004872-200401000-00021","article-title":"Insulin-mediated regulation of the endothelial renin-angiotensin system and vascular cell growth.","volume":"22","author":"K Kamide","year":"2004","journal-title":"J Hypertens"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0952-3278(92)90143-7","article-title":"Modulation of prostacyclin production by cytokines in vascular endothelial cells.","volume":"47","author":"A Ristimaki","year":"1992","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1152\/physrev.00011.2005","article-title":"Heme oxygenase-1\/carbon monoxide: from basic science to therapeutic applications.","volume":"86","author":"SW Ryter","year":"2006","journal-title":"Physiol Rev"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.4049\/jimmunol.179.11.7840","article-title":"Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276.","volume":"179","author":"MP Seldon","year":"2007","journal-title":"J Immunol"},{"key":"ref104","first-page":"363","article-title":"Heme oxygenase-1 transduction in endothelial cells causes downregulation of monocyte chemoattractant protein-1 and of genes involved in inflammation and growth.","volume":"51","author":"D Sacerdoti","year":"2005","journal-title":"Cell Mol Biol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1097\/01.tp.0000290233.81395.81","article-title":"Induction of heme oxygenase-1 improves the survival of pancreas grafts by prevention of pancreatitis after transplantation.","volume":"84","author":"T Becker","year":"2007","journal-title":"Transplantation"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MPA.0b013e31815ceb0e","article-title":"Protective role of heme oxygenase-1 in pancreatic microcirculatory dysfunction after ischemia\/reperfusion in rats.","volume":"36","author":"E von Dobschuetz","year":"2008","journal-title":"Pancreas"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.critrevonc.2005.12.003","article-title":"Regulation of angiogenesis by hypoxia-inducible factor 1.","volume":"59","author":"K Hirota","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tcm.2007.08.005","article-title":"Stem cell therapy for vascular disease.","volume":"17","author":"B Adams","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00125-008-1021-0","article-title":"An underlying principle for the study of circulating progenitor cells in diabetes and its complications.","volume":"51","author":"GP Fadini","year":"2008","journal-title":"Diabetologia"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm948","article-title":"Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells.","volume":"9","author":"A Aicher","year":"2003","journal-title":"Nat Med"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.molmed.2004.02.001","article-title":"Role of eNOS in neovascularization: NO for endothelial progenitor cells.","volume":"10","author":"DG Duda","year":"2004","journal-title":"Trends Mol Med"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","article-title":"Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.","volume":"115","author":"S Nakao","year":"2005","journal-title":"J Clin Invest"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1677\/joe.1.05676","article-title":"Lack of compensatory increase in islet blood flow and islet mass in GK rats following 60% partial pancreatectomy.","volume":"184","author":"AM Svensson","year":"2005","journal-title":"J Endocrinol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.coph.2004.03.010","article-title":"Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation.","volume":"4","author":"CA Dinarello","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1016\/j.febslet.2006.10.061","article-title":"IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?","volume":"580","author":"S Perrier","year":"2006","journal-title":"FEBS Lett"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.2337\/diabetes.51.12.3582","article-title":"Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes.","volume":"51","author":"R Marculescu","year":"2002","journal-title":"Diabetes"},{"key":"ref117","article-title":"Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction.","author":"R van Minkelen","year":"2008"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/104454999314999","article-title":"An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta.","volume":"18","author":"Y Xu","year":"1999","journal-title":"DNA Cell Biol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/mp060091s","article-title":"Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function.","volume":"4","author":"X Jia","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.2337\/diabetes.47.10.1602","article-title":"Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.","volume":"47","author":"KA Wadt","year":"1998","journal-title":"Diabetes"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI6438","article-title":"Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release.","volume":"104","author":"K Hostens","year":"1999","journal-title":"J Clin Invest"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mce.2005.06.001","article-title":"Cytokines affect PDX-1 expression, insulin and proinsulin secretion from iNOS deficient murine islets.","volume":"240","author":"AK Andersson","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1677\/joe.1.06676","article-title":"Altered proinsulin conversion in rat pancreatic islets exposed long-term to various glucose concentrations or interleukin-1beta.","volume":"192","author":"A Borjesson","year":"2007","journal-title":"J Endocrinol"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"13163","DOI":"10.1073\/pnas.0801059105","article-title":"Interleukin-6 regulates pancreatic alpha-cell mass expansion.","volume":"105","author":"H Ellingsgaard","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s001250050768","article-title":"Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.","volume":"40","author":"J Movassat","year":"1997","journal-title":"Diabetologia"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.pharmthera.2005.11.003","article-title":"From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: Epoxyeicosatrienoic acids (EETs) and cell signaling.","volume":"111","author":"UR Michaelis","year":"2006","journal-title":"Pharmacol Ther"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tips.2006.11.002","article-title":"Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system.","volume":"28","author":"BT Larsen","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function.","volume":"292","author":"AA Spector","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.","volume":"285","author":"K Node","year":"1999","journal-title":"Science"},{"key":"ref130","article-title":"Administration of a substituted adamantly-urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.","author":"JJ Olearczyk","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/FJC.0b013e318185fa3c","article-title":"Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model.","volume":"52","author":"A Ulu","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0955-2863(99)00033-9","article-title":"A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection.","volume":"10","author":"S Melnyk","year":"1999","journal-title":"J Nutr Biochem"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1016\/j.febslet.2006.10.052","article-title":"Site specific changes of redox metabolism in adipose tissue of obese Zucker rats.","volume":"580","author":"A Galinier","year":"2006","journal-title":"FEBS Lett"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0009-9120(94)00073-5","article-title":"Measurement of homocyst(e)ine in the prediction of arteriosclerosis.","volume":"28","author":"LJ Fortin","year":"1995","journal-title":"Clin Biochem"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1210\/endo.132.2.8425496","article-title":"Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes.","volume":"132","author":"MH Giroix","year":"1993","journal-title":"Endocrinology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0006963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T02:09:52Z","timestamp":1590113392000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0006963"}},"subtitle":[],"editor":[{"given":"Kathrin","family":"Maedler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,9,9]]},"references-count":135,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0006963","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,9]]}}}